Who is sponsoring NCT02571283?

NCT02571283 is sponsored by University of Louisville.

What condition does NCT02571283 study?

NCT02571283 studies Total Knee Arthroplasty, Pain Management.

What drugs are being tested in NCT02571283?

Interventions: Cocktail, Exparel, Marcaine.

What is the status of NCT02571283?

NCT02571283 is currently WITHDRAWN.

Last reviewed 2017-04-05 · How we verify

A Randomized, Prospective Trial Comparing Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel

NCT02571283 Phase 4 WITHDRAWN

A prospective, randomized control study will be conducted to compare postoperative pain control in a series of patients treated with either: 1. a local cocktail. 2. a local cocktail plus Exparel. 3. marcaine plus Exparel prior to wound closure following knee arthroplasty.

Details

Lead sponsor	University of Louisville
Phase	Phase 4
Status	WITHDRAWN
Start date	2015-10
Completion	2016-05

Conditions

Total Knee Arthroplasty
Pain Management

Interventions

Cocktail
Exparel
Marcaine

Primary outcomes

The visual pain scale from 1-10 will be used to determine changes in pain control at 3, 12, 24, and 48 hour time intervals postoperatively. — Pain control intervals will be assessed at 3, 12, 24, and 48 hour time intervals postoperatively.